Company News

Announcement of the latest technology for cell culture and process optimization

Introducing a list of cell culture medium brands at a dedicated booth

Ajinomoto CELLiST Korea, a cell culture medium research and manufacturing company, will participate in

'Biologics Manufacturing Asia 2024 (BMA 2024)'

held at the Sands Expo & Convention Center in Singapore for two days from March 20th to 21st. He said he would.

BMA, which celebrated its 11th anniversary this year, is a global conference focusing on bioprocessing.

It is a networking venue where experts from companies and academia with a biopharmaceutical industry base in each region of

Asia gather to share know-how in manufacturing and developing high-quality biopharmaceuticals and vaccines. am.

BMA 2024 will be attended by a total of 1,300 people from more than 300 companies in the Asia Pacific region,

and key players in the biopharmaceutical industry will appear as speakers and reveal the latest knowledge.

There will also be networking time to foster opportunities for collaboration among related companies and organizations.

Ajinomoto CELLiST Korea, participating as a platinum sponsor of the event, plans to unveil the latest technology for

biopharmaceutical manufacturing under the theme of ‘Development of Advanced Feed Media and Supplement for a Robust,

Cost-Effective and High-Performance Process’. In addition, a separate dedicated booth will be set up to introduce the latest

cell culture medium products such as CELLiST and comprehensive customer support services.

Ajinomoto CELLiST Korea established Korea's first cell culture medium factory in 2012 and has been supplying CELLiST,

a cell culture medium for biopharmaceuticals, in the Asia Pacific and European regions. Cellist is a cell culture medium brand

developed based on Ajinomoto's medium manufacturing technology and know-how that has been researching

chemical cell culture media for over 30 years.

It contains high-quality amino acids based on Ajinomoto's amino acid research capabilities and expertise.

We attempted to differentiate ourselves by achieving both excellent cell growth speed and protein production ability.

An official from Ajinomoto CELLiST Korea said, “As amino acids are an essential ingredient in media,

our company utilizes Ajinomoto’s advanced technology and know-how on amino acids to manufacture high-quality media

optimized according to customer needs. “By leveraging these strengths, we will contribute to the well-being of people,

society, and the region by providing a variety of solutions to pharmaceutical and bio companies around the world,”

he said. “We will spread the cell list containing high-quality amino acids backed by amino acid research capabilities and expertise.”

“We ask for your interest and expectations as we participated in the BMA this year as well as last year to raise awareness and

contribute to the development of the biopharmaceutical industry.”

Meanwhile, BMA is an event hosted by the social enterprise IMAPAC and is held every year in Singapore.

Since 2014, IMAPAC has been holding various conferences every year with more than 400 experts participating

from more than 100 countries, including governments, NGOs, related companies, and academia.